top of page
Using genetics to identify drug targets and match individuals with medication
PolygenRx is a pharmaceutical company using genetics to inform drug discovery and precision medicine for complex disorders. We are excited about the potential of our platform to revolutionize the treatment of chronic disease through targeted therapies.
Matching people to their optimal treatment
Our propriety platform is essentially a matchmaking service between patients and drugs, allowing treatment to be optimised for each individual using their unique combination of genetic risk factors. This approach increases the likelihood of a newly developed drug achieving regulatory approval and can also be used to rescue drugs that have previously failed in clinical trials.
Newcastle, NSW, Australia
​
Keywords: PolygenRx; precision medicine; companion diagnostics; targeted therapy; polygenic architecture; drug development, drug discovery; drug repurposing; pharmaceuticals; chronic disease; genetics; pharmagenic enrichment score (PES).
© 2022 PolygenRX
Website design and development by Rosalie Grierson-Burgess
bottom of page